Dr. Erntoff, MD
Claim this profileRoswell Park Cancer Institute
Studies Neuroendocrine Carcinoma
Studies Cancer
1 reported clinical trial
2 drugs studied
Area of expertise
1Neuroendocrine Carcinoma
Stage IV
metastatic
talimogene laherparepvec [T-VEC]
2Cancer
Stage IV
metastatic
talimogene laherparepvec [T-VEC]
More about Erntoff, MD
Clinical Trial Related4 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Erntoff, MD has experience with
- Atezolizumab
- NT-I7
Breakdown of trials Erntoff, MD has run
Neuroendocrine Carcinoma
Squamous Cell Carcinoma
Merkel Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Erntoff, MD specialize in?
Erntoff, MD focuses on Neuroendocrine Carcinoma and Cancer. In particular, much of their work with Neuroendocrine Carcinoma has involved Stage IV patients, or patients who are metastatic.
Is Erntoff, MD currently recruiting for clinical trials?
No, Erntoff, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Erntoff, MD has studied deeply?
Yes, Erntoff, MD has studied treatments such as Atezolizumab, NT-I7.
What is the best way to schedule an appointment with Erntoff, MD?
Apply for one of the trials that Erntoff, MD is conducting.
What is the office address of Erntoff, MD?
The office of Erntoff, MD is located at: Roswell Park Cancer Institute, Buffalo, New York 14263 United States. This is the address for their practice at the Roswell Park Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.